The fda panel is sort of contradicting itself for approving Dmabb for prostate cancer bone loss and not for cancer related bonelossThe FDA in October could approve it for all cancer related bonelossThe news is good. Dmab is approved and doctors can perscribe it for other indications even without FDA OKThe news is good. AMGN has a drug that has huge potentioal jusk like Avastin was for genentech
the drug is approved for (1) treatment of osteoporosis and (2) treatment of bone loss in prostate cancerit is rejected for (1) prevention of osteoporosis (2) prevention of bones loss in prostate cancer (3) prevention of bone loss in breast cancer and (4) treatment of bone loss in breast cancer.
Where are you getting this information? I would like to monitor it myself if possible. The only article out talks about PMO treatment and prevention.
it is on my td ameritrade streamer also -- news is correct